Literature DB >> 24160364

Why do patients discontinue antidepressant therapy early? A qualitative study.

Mariesha Jaffray1, Amanda H Cardy, Ian C Reid, Isobel M Cameron.   

Abstract

BACKGROUND: Current guidelines for antidepressant prescribing are that treatment should be continued following the resolution of symptoms: six months after a first episode and for at least two years for those with previous episodes. Despite this, sub-optimal treatment duration still predominates. Patients have negative and positive views on antidepressants, which change throughout their treatment journey.
OBJECTIVES: To explore views and experiences of patients recently initiated on antidepressants (within six months), and to consider the influences on early discontinuation.
METHODS: A qualitative interview study was used in four general practices in the North East of Scotland. A purposive sample of primary care patients, newly initiated on antidepressants, was interviewed to explore views and experiences with antidepressant therapy. Interviews were audio-recorded and transcribed verbatim. Thematic analysis was conducted using a consensus coding frame developed by two researchers.
RESULTS: Twenty-nine patients participated. Three main factors influencing discontinuation were identified: ownership, knowledge and support. The treatment journey was characterized by four important time points where health care intervention may be helpful.
CONCLUSION: Health care professionals would benefit from exploring patient knowledge and views on depression and antidepressants at an early stage in treatment. Patients would welcome active involvement in treatment decision making, the provision of information and ongoing support.

Entities:  

Keywords:  adherence; antidepressants; attitudes; depression; general practice; stigma

Mesh:

Substances:

Year:  2013        PMID: 24160364     DOI: 10.3109/13814788.2013.838670

Source DB:  PubMed          Journal:  Eur J Gen Pract        ISSN: 1381-4788            Impact factor:   1.904


  6 in total

1.  Neighbourhood Material and Social Deprivation and Exposure to Antidepressant Drug Treatment: A Cohort Study Using Administrative Data.

Authors:  Sophie Lauzier; Hichem Kadachi; Jocelyne Moisan; Alain Vanasse; Alain Lesage; Marie-Josée Fleury; Jean-Pierre Grégoire
Journal:  Can J Psychiatry       Date:  2018-03-07       Impact factor: 4.356

2.  Clinical characteristics associated with therapeutic nonadherence of the patients with major depressive disorder: A report on the National Survey on Symptomatology of Depression in China.

Authors:  Qian Zhou; Zhi-Guo Wu; Yun Wang; Xiao-Hua Liu; Jun Chen; Yong Wang; You-Song Su; Chen Zhang; Dai-Hui Peng; Wu Hong; Yi-Ru Fang
Journal:  CNS Neurosci Ther       Date:  2018-07-11       Impact factor: 5.243

3.  Patient perspectives on the role of community pharmacists for antidepressant treatment: A qualitative study.

Authors:  Laurence Guillaumie; Alice Ndayizigiye; Clément Beaucage; Jocelyne Moisan; Jean-Pierre Grégoire; Denis Villeneuve; Sophie Lauzier
Journal:  Can Pharm J (Ott)       Date:  2018-02-09

4.  Guidance by physicians and pharmacists during antidepressant therapy: patients' needs and suggestions for improvement.

Authors:  Mariёtte Nederlof; Daniёlle C Cath; Lennart J Stoker; Toine C G Egberts; Eibert R Heerdink
Journal:  BMC Psychiatry       Date:  2017-12-04       Impact factor: 3.630

5.  'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses.

Authors:  Chris F Johnson; Brian Williams; Stephen A MacGillivray; Nadine J Dougall; Margaret Maxwell
Journal:  BMC Fam Pract       Date:  2017-06-17       Impact factor: 2.497

6.  Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study.

Authors:  Pornchanok Srimongkon; Parisa Aslani; Timothy F Chen
Journal:  Patient Prefer Adherence       Date:  2018-09-19       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.